PDS Biotechnology Corp
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-34.5M | $-37.6M | $-42.9M | $-40.9M | $-16.9M | $-14.8M | $-7.0M | $-3.8M |
| Depreciation & Amortization | — | — | — | — | — | $15.6K | $98.4K | $69.1K |
| Depreciation | $21.8K | $21.1K | $17.4K | $86 | $5.4K | $15.6K | $98.4K | $23.3K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $4.1M | $6.8M | $7.6M | $5.2M | $4.1M | $432.3K | $3.1M | $866.8K |
| Net Cash from Operating Activities | $-27.8M | $-35.0M | $-33.6M | $-25.7M | $-12.5M | $-13.1M | $-18.1M | $-1.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $29.0K | $0 | — | — | — | — | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $-29.0K | $0 | — | — | $0 | $29.4M | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.8M | $20.2M | $16.4M | $34.3M | $48.9M | $29.8M | $750.0K | $1.5M |
| Net Change in Cash | — | — | — | — | — | — | — | $-53.4M |
| Free Cash Flow | $-27.8M | $-35.1M | $-33.6M | — | — | — | — | $-1.6M |